Archive for September, 2012

Recent Rosacea Blog Posts

Scenesse has been tested as a treatment for acne, and the results are looking good. Before you get too excited, though, lets get all the disclaimers out of the way right up front … Clinuvel, the developers of Scenesse are not currently pursuing Scenesse as a treatment for acne The study presented was very small, […]

Continue Reading

All You Ever Wanted to Know About Demodex Mites

If you search for demodex using Google’s Scholar search, you will find over 8,000 papers that mention them. Further if you search for demodex and rosacea you will get nearly 2,000 results. So there has been plenty of research into the topic. Whilst a clear causal link between the mites and rosacea has not yet […]

Continue Reading

The National Rosacea Society is 20 Years Old

A recent blog posting from the NRS has mentioned that this month the National Rosacea Society is 20 years old. NRS Celebrates 20 Years Thursday, September 6, 2012 The National Rosacea Society (NRS) marks its 20th anniversary in 2012, and is pleased to report on the vast ongoing progress that has been made toward fulfilling […]

Continue Reading

Dermatology Times today has an article that confirms some insights into the recent Phase II study into the safety and efficacy of different strengths of the Sansrosa Gel. The article adds some personal insights into the trial from the principal investigator, Dr. Joseph Fowler MD. This is not the most recent news as Rosacea News […]

Continue Reading

Redless Specific Serum from Integral Dermo Correction

A just published paper alludes to a new redness reducing cosmeceutical. The product is referred to as 100RXED2025, but it looks likely that the actual product name is the multi syllabic mouthful “Integral Dermo Correction Redless Anti-Redness Facial Serum”. In other publicity it is also called Redless Specific Serum. The product claims to be comprised […]

Continue Reading



Subscribe to Rosacea News

Enter your email address to receive the latest news about rosacea in your inbox.